6505--762_Pharmaceuticals_VA CMOP Tucson_36C77025Q0180 762-25-2-040-1379 -Tucson CMOP LURASIDONE
ID: 36C77025Q0180Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)

Original Source

https://sam.gov/opp/581a25e5dbed4ac1a6cc761fbc3d36aa/view
Timeline
    Description

    The Department of Veterans Affairs is seeking qualified vendors to supply Lurasidone HCL 20mg tablets in 30-count bottles for the Tucson CMOP facility under solicitation number 36C77025Q0180. The procurement aims to fulfill a standard requirement for essential pharmaceuticals, emphasizing compliance with the Buy American statute and the Drug Supply Chain Security Act (DSCSA). This opportunity is critical for ensuring that veterans receive necessary medications in a timely manner, with a delivery timeframe of 10 days after receipt of order. Interested vendors must submit their quotes, including a signed SF1449 cover page, price schedule in Excel format, and a completed Buy American Certificate, to Michael W McAlhaney at Michael.McAlhaney@va.gov by March 19, 2025, with an estimated award date of March 24, 2025.

    Point(s) of Contact
    McAlhaney, Michael W.Contract Specialist
    (913) 684-0134
    Michael.McAlhaney@va.gov
    Files
    Title
    Posted
    36C77025Q0180_1.docx
    This document outlines a Request for Quotes (RFQ) issued by the Department of Veterans Affairs for pharmaceutical supplies, specifically for Lurasidone HCL 20mg tablets in 30-count bottles. The request emphasizes a preference for U.S.-made products and mandates adherence to the Drug Supply Chain Security Act (DSCSA) for all vendors. The RFQ contains a detailed checklist of required documentation, including a signed Standard Form 1449, price schedule in Excel, state wholesale distributor license, and a completed Buy American certificate. The delivery terms specify that products must be shippable by the United States Postal Service (USPS), and deliveries must be coordinated with the receiving facility. Vendors must provide a firm commitment of availability and pricing and ensure packaging meets all standards, including bar coding and labeling requirements. Additionally, procedures for handling product recalls and invoicing guidelines are included, emphasizing the importance of compliance with federal regulations. The document serves as an essential guide for prospective contractors to ensure compliance with government acquisition policies while providing critical pharmaceutical goods to veterans' healthcare services.
    36C77025Q0180.docx
    The presolicitation notice from the Department of Veterans Affairs outlines a requirement for procurement of pharmaceuticals, specifically Lurasidone HCL 20mg tablets, to be delivered to the Tucson CMOP facility. The solicitation number is 36C77025Q0180, with a response deadline set for March 19, 2025. It is a small business set-aside, and suppliers must comply with the Buy American statute by providing separate quotes for both domestic and foreign products. Key submission components include a signed SF1449, a price schedule in Excel format, proof of state wholesale distributor licensure, and completion of the Buy American certificate. Offers must be submitted electronically to the designated contact, Michael McAlhaney. The expected delivery timeframe is 10 days after receipt of order, and goods must be shipped at the vendor's expense. This presolicitation reflects governmental efforts to ensure compliance with pharmaceutical supply chain regulations while supporting small business participation in federal contracts.
    52.225-2 BUY AMERICAN CERTIFICATE.docx
    The "Buy American Certificate" provision (FAR 52.225-2) outlines requirements for Offerors in federal procurement to certify the domestic origin of their end products. Offerors must declare each end product's domestic status and list any foreign products, indicating their country of origin and domestic content percentage, particularly if it exceeds 55%. The document specifies definitions for terms like "commercially available off-the-shelf (COTS) item" and "critical component." Furthermore, Offerors are required to identify domestic products containing critical components and must adhere to evaluation policies established in part 25 of the Federal Acquisition Regulation. This provision's purpose is to ensure that the government prioritizes domestic products in procurement processes, thereby supporting national manufacturing and economic interests.
    S02_Solicitation_Attachment_Pricing SpreadSheet_RFQ_36C77025Q0180.xlsx
    This document outlines a federal Request for Quotation (RFQ) for the procurement of Lurasidone HCL 20mg tablets in 30-count bottles, referenced as RFQ: 36C77025Q0180. The RFQ has an expected issue date of March 12, 2025, with responses due by March 19, 2025. Award notifications are anticipated by March 24, 2025, and the delivery window is slated for April 7, 2025. All suppliers must adhere to the Drug Supply Chain Security Act (DSCSA) and provide documentation, including state wholesale distributor licenses, in compliance with federal regulations. Noncompliance will result in technical unacceptability. Required submission documents include the signed SF1449 cover page, a price schedule in Excel format, and the completed Buy American Certificate. Correspondence and documentation must be sent to designated CMOP procurement email addresses. The RFQ reflects a commitment to maintaining regulatory standards while fulfilling government procurement needs for essential pharmaceutical products.
    Similar Opportunities
    6505--762-25-2-040-1078 -Tucson CMOP ESCITALOPRAM OXALATE -(VA-25-00049225)
    Buyer not available
    The Department of Veterans Affairs is preparing to procure Escitalopram Oxalate 20mg tablets for the Tucson Consolidated Mail Outpatient Pharmacy (CMOP). This presolicitation notice, identified by contract number 36C77025Q0169, outlines the requirement for timely delivery of the pharmaceutical product within 10 days after order receipt, emphasizing compliance with the Drug Supply Chain Security Act (DSCSA). The procurement is set aside for small businesses under the NAICS code 325412, with a response deadline of March 13, 2025, at 3 PM Central Time. Interested vendors should submit their quotes via email, including necessary documentation, and are encouraged to monitor SAM.gov for updates.
    6505--762_Pharmaceuticals_VA CMOP Tucson_36C77025Q0179 762-25-2-040-1352 -Tucson CMOP HYDROCORTISONE
    Buyer not available
    The Department of Veterans Affairs is seeking bids for the procurement of Hydrocortisone Acetate pharmaceuticals to be delivered to its Tucson CMOP facility under solicitation number 36C77025Q0179. The requirement includes specific quantities of two formulations of Hydrocortisone Acetate, each in different package sizes, and the opportunity is set aside for small businesses. This procurement is crucial for enhancing the supply chain capabilities to meet the medical needs of veterans, with a response deadline of March 18, 2025, and an estimated award date of March 21, 2025. Interested vendors must submit their bids via email to Contract Specialist Michael W. McAlhaney, including a signed SF1449 cover page, an Excel-based price schedule, a valid state wholesale distributor license, and a completed Buy American certificate.
    6505--762-25-1-040-0304 -Tucson CMOP PROPRANOLOL -(VA-25-00021631)
    Buyer not available
    The Department of Veterans Affairs is seeking qualified vendors to provide Propranolol for the Tucson Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0137. This procurement focuses on the delivery of high-quality pharmaceutical supplies, emphasizing compliance with shipping standards, packaging, and invoicing requirements, while also supporting small business participation through set-asides for HUBZone and women-owned businesses. The products must meet specific standards, including national drug codes and therapeutic equivalence, with a minimum expiration date of one year from delivery. Interested vendors must submit their quotes by March 14, 2025, at 3:00 PM CT, and can contact Lacie A Nowak at lacie.nowak@va.gov for further details.
    6505--Fludrocortisone Acetate Tablets (VA-25-00047932)
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for Fludrocortisone Acetate 0.1MG Tablets, packaged in bottles of 100 tablets, to ensure a reliable supply for various federal entities, including the Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The procurement aims to award a single contract that covers an initial term of one year, with the option for four additional one-year periods, thereby securing an uninterrupted source of this essential medication. The estimated annual requirement for the tablets is 31,127 bottles, and interested suppliers must provide a unique NDC or UPC number along with the product name as it appears on the label. The solicitation is expected to be published on or around March 28, 2025, with proposals due by April 11, 2025; inquiries can be directed to Youlanda Duggar at Youlanda.Duggar@va.gov or by phone at 708-786-4943.
    6509--Solifenacin Tabletes (VA-25-00037090)
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Solifenacin Tablets, designated as RFP 36E79725R0020. This procurement aims to establish a reliable supply of Solifenacin for the VA, Department of Defense (DoD), and other federal health agencies, with the contract expected to last one year and include four optional renewal periods. Solifenacin is a critical medication used in the treatment of overactive bladder, highlighting the VA's commitment to ensuring access to essential pharmaceuticals for veterans and associated healthcare providers. Interested vendors should monitor SAM.gov for the RFP release, anticipated around March 14, 2025, with proposals due by March 28, 2025; for further inquiries, they may contact Contract Specialist Kenneth Lay at Kenneth.Lay@va.gov or by phone at 708-786-4879.
    6505--Hydroxychloroquine SO4 Tablets
    Buyer not available
    The Department of Veterans Affairs (VA) is issuing a Request for Proposal (RFP) for the procurement of Hydroxychloroquine SO4 Tablets, aimed at ensuring a continuous supply for various federal entities, including the Department of Defense and the Bureau of Prisons. The contract will cover an estimated annual requirement of 163,395 bottles of 100-count and 25,853 bottles of 500-count Hydroxychloroquine tablets, with a contract period of one year and four optional one-year extensions. This procurement is critical for maintaining essential medications within veteran and federal healthcare programs. Interested parties should monitor SAM.gov for updates and direct inquiries to the contracting officer, Chris Carthron, at Christopher.Carthron@va.gov or (708) 786-4980, with submissions due by March 26, 2025.
    6505--Loperamide Capsules (VA-25-00032225)
    Buyer not available
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for the procurement of Loperamide HCL 2MG Capsules under Request for Proposal (RFP) 36E79725R0025. This procurement aims to ensure a consistent supply of the medication not only for the VA but also for the Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC), with the intention to award one contract that spans one year with four optional one-year extensions. The estimated requirements include 18,690 bottles of 100 capsules and 47,289 bottles of 500 capsules annually, reflecting the importance of maintaining a steady supply of essential medications for healthcare facilities. Interested parties should note that the solicitation is expected to be electronically issued by April 17, 2025, with responses due by May 1, 2025; inquiries can be directed to Contracting Officer Andrew Cazares at Andrew.Cazares@va.gov or (719) 786-4990.
    6505--Carvedilol Tablets (VA-25-00048048)
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Carvedilol Tablets under solicitation number 36E79725R0028, aimed at ensuring a continuous supply for various federal health care entities, including the Department of Defense and the Bureau of Prisons. The contract will be for one year, with the possibility of four additional one-year extensions, requiring offerors to supply drugs labeled with their unique National Drug Code (NDC) without altering existing labels. This procurement is critical for maintaining the availability of essential medications for veterans and affiliated populations, underscoring the VA's commitment to effective health care delivery. Interested bidders should monitor SAM.gov for updates, with the RFP expected to be issued around March 19, 2025, and responses due by April 2, 2025; inquiries can be directed to Contract Specialist Adrienne Albachiara at adrienne.albachiara@va.gov or by phone at 708-202-9027.
    6505--Aprepitant Capsules
    Buyer not available
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0029 concerning the procurement of Aprepitant Capsules, aimed at ensuring a continuous supply for various federal entities, including the Department of Defense and the Bureau of Prisons. Offerors are required to provide a unique National Drug Code (NDC) number and ensure that their label is the sole representation on the product, with the contract set for one year plus four optional annual extensions. This procurement is critical for serving veterans and other federal health care facilities, with substantial estimated annual requirements for Aprepitant in various dosages. Interested parties should note that the solicitation will be released around March 25, 2025, with a closing date of April 8, 2025, and are encouraged to contact Matthew Poulin at matthew.poulin@va.gov for inquiries.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.